Appointments feel relaxed and thoughtful
In clinical trials, the combination injectable Soliqua has demonstrated effective sugar control, without weight gain and with lower risk of hypoglycemia, compared to twice daily premix insulins. Soliqua is a once-daily injectable combination drug containing insulin glargine 100 Units/ml, which is a long-acting basal insulin and lixisenatide, a GLP-1 receptor agonist
On the phone for an hour today with Customer service & after 25 login attempts it still doesnt work
[ref] One study explains that bacterial overgrowth and leaky gut interact with pancreatic inflammation allowing translocation of bacteria and toxins to the pancreas. Additionally, about one-third of chronic pancreatitis patients are also diagnosed with small-intestinal bacterial overgrowth (SIBO).[ref] In a case-control study of hospitalized patients with acute pancreatitis, the pancreatitis patients had a higher abundance of sulfidogenic bacteria in their intestines and higher serum hydrogen sulfate levels
drugmaker's popular injectable therapy raked in 1 billion rupees ($11.38 million) in October, research firm Pharmarack said
This was published 4 months ago Opinion Its the elephant in the jockeys room